
Lifestyle changes-more exercise, taking omega-3 supplements-may help those with dementia, and a protein found in the brain may be a marker for Parkinson disease. Details here.

Lifestyle changes-more exercise, taking omega-3 supplements-may help those with dementia, and a protein found in the brain may be a marker for Parkinson disease. Details here.

The amyloid-β42/40 ratio should be included as a cerebrospinal fluid biomarker for Alzheimer disease, according to a new study.

Given the impact of sleep on quality of life, cognitive functioning, and health outcomes, understanding sleep disorders in older adults is vital to their overall care.

What are the symptoms and treatment strategies for this rapidly growing phenomenon in older adults?

Three new studies on genetic risk factors and lifestyle; the transition from cognitive health to Alzheimer disease; and metabolic syndrome in depressed older adults.

New-onset neuroticism and guardedness may be incipient signs of Alzheimer Disease, according to a new study.

The cases presented here illustrate the complexities of memory loss and psychiatric comorbidities.

While opioid use disorders are more common in younger patients, prevalence among the elderly is growing.

This Special Report on Geriatric Psychiatry addresses a variety of clinical issues in the rapidly growing diverse population of older adults.

Some of the thorniest ethical dilemmas in psychiatry evolve around food: forced feeding in anorexia nervosa, artificial nutrition and hydration at the end of life, and the covert administration of psychotropic medications

Among the topics covered in this year's noteworthy studies: lithium and suicide prevention, mixed depression, and light therapy.

These common conditions may affect the risk of Alzheimer disease or the ability to cope with daily activities.

What underlies the higher prevalence of Alzheimer disease among older African Americans?

Hypertension, loss of sense of smell, personality changes: which can predict dementia?

A look at sex differences in the neuropsychological deficits of Alzheimer disease.

When, if ever, is it ethical to administer a medication to a patient-even an incapacitated one-without his knowledge? Read the case, and weigh in.

New tools for the armamentarium: a patient self-management app, a retinal imaging system, and a computer program for Alzheimer diagnosis.

Blood-based vibrational spectroscopy shows promise as a screening tool for dementia.

Persons with dementia can still retain the capacity to experience humor, joy, and mutual interactions. Therein lie the seeds of a new perspective on aging.

Are you up-to-date on the latest findings in mild cognitive impairment, dementia, and depression in elderly patients?

A look at the impact of shift work and long hours on cognitive function.

What factors predispose patients to TRD and what treatment strategies achieve response? Find out here, with a bonus case vignette.

Here: what psychiatrists need to know about frontotemporal dementia. Case examples convey the variety of possible psychiatric presentations of behavioral variant FTD.

Researchers investigate Alzheimer disease in 3 key areas: sleep, seizures, and proton pump inhibitors.

Recent findings challenge the notion that these agents can provide sustained protection against cognitive decline.